Yuekang “Alex” has signed contracts with more than 60 large channels to achieve Wuxi Online Offline Communication Information Technology Co.Ltd(300959) full coverage

On January 18, Youcare Pharmaceutical Group Co.Ltd(688658) (688658. SH) held the unlisted press conference and sales signing ceremony of ADINA citrate in Guangzhou. At the press conference, Youcare Pharmaceutical Group Co.Ltd(688658) signed cooperation agreements with more than 60 channel providers such as authoritative media, online platforms, OTC chain pharmacies and offline terminals.

Youcare Pharmaceutical Group Co.Ltd(688658) said that for Alex brand, Youcare Pharmaceutical Group Co.Ltd(688658) has formulated a sales strategy of new media brand leadership and omni-channel coverage. The company will make strong efforts in the four sales channels of e-commerce channel, OTC chain drugstore, the third terminal and hospital market, empower and channel the company’s partners around brand building, marketing event planning and news event driving, and realize sales coverage in all fields.

It is reported that Alex aldenafil citrate is the first original innovative drug of anti ed (erectile dysfunction) class 1.1 in China. Academician Guo yinglu of the Chinese Academy of Engineering led the team to guide the clinical trial. Alex has a new chemical structure. Compared with similar products, Alex has better medication experience, higher safety and less side effects, And has patents in 22 countries and regions around the world.

Mr. Yu Weishi, chairman of Youcare Pharmaceutical Group Co.Ltd(688658) said that the birth of Alex is a milestone in the development process of yuekang. In addition, yuekang currently focuses on developing 13 class 1 new drugs, and many heavy products are expected to accelerate the listing. In the future, Youcare Pharmaceutical Group Co.Ltd(688658) will focus on advantageous fields such as cardio cerebrovascular, anti-tumor and infectious diseases, actively explore innovative products and come up with a large number of excellent products to repay patients, investors and society.

Youcare Pharmaceutical Group Co.Ltd(688658) will cooperate with various channels to continue to layout the digital national marketing network, optimize information management technology, innovate member operation system, achieve deeper cooperation, and realize strong cooperation and win-win results.

This time Youcare Pharmaceutical Group Co.Ltd(688658) we have reached strategic cooperation with many channels to lay out the development of the whole industrial chain. There were four rounds of signing at the press conference, and 60 channel providers signed cooperation agreements with Youcare Pharmaceutical Group Co.Ltd(688658) . Including 1 medicine network, ark Jianke, baidu health, Ali health pharmacy, Dingdang fast medicine and other major e-commerce platforms. In terms of offline terminal channels, Youcare Pharmaceutical Group Co.Ltd(688658) has signed cooperation agreements with 60 channel providers such as Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy, Yifeng pharmacy, Shuyu Civilian Pharmacy Corp.Ltd(301017) , Guangdong Kangze pharmaceutical chain Co., Ltd., Zhejiang Yunkai Yamei Pharmaceutical Technology Co., Ltd., Beijing Dekai Pharmaceutical Technology Co., Ltd., Guangdong hengjintang pharmaceutical chain Co., Ltd. and Hangzhou Shijing pharmacy chain Co., Ltd. Youcare Pharmaceutical Group Co.Ltd(688658) in the future, it will also carry out strategic cooperation with more valuable and influential channels to jointly create a new pattern of China’s anti ed drug market.

- Advertisment -